TheEdgeResearch
Home / Stocks / CYPS

Cyclo3pss Corporation (CYPS)

OTC Healthcare Medical - Diagnostics & Research
$0.00 ▲ +0.00%
Market Cap
$4,054
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
-0.76
52-Wk Range
0.00001-0.0001
CEO
William R. Stoddard
Country
US
Currency
USD

Cyclo3pss Corporation operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Salt Lake City, UT, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $4,054. Its beta of -0.76 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
4
IPO date
2010-07-28
Headquarters
Salt Lake City, UT, US
About Cyclo3pss Corporation

Cyclo3pss Corporation operated primarily in the ozone technology sector. Its business encompassed the licensing, manufacturing, sales, and installation of ozone-based products for food processing, as well as providing ozone washing, sorting, and counting systems for commercial and institutional laundries. Additionally, the firm was involved in the research and development of sterilization and disinfection technologies for various consumer goods. Established in Salt Lake City, Utah, the company traced its origins back to 1927. However, in July 2002, Cyclo3pss's Board of Directors made the decision to immediately cease all company operations. This drastic step was taken due to an inability to attract willing investors and secure the essential financing required for continued business.

Comparable companies

Cyclo3pss Corporation is most often compared with the following Healthcare names:

CVHIFEMGEKLDONMRDNMXSREMITHCTTNGNQUPHVIVE
More research on CYPS
CYPS technical analysis CYPS TheEdge Score Compare against peers
Open full interactive analysis & DCF →